Search results for "Coronavirus"
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
Third shot for immunocompromised patients, ACP and others urge vaccine in pregnancy, more COVID-19 news
The FDA and multiple new studies supported a third vaccine dose for organ transplant patients, an ACP statement and an observational trial highlighted benefits of vaccination during pregnancy, and a randomized trial found benefit from budesonide in high-risk outpatients with COVID-19.
https://immattersacp.org/weekly/archives/2021/08/17/1.htm
17 Aug 2021
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021
Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health
Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
https://immattersacp.org/weekly/archives/2021/08/03/4.htm
3 Aug 2021
ACP hosts free webinar, “COVID-19 Recovery: Increasing Adult Vaccinations”
Topics covered will include current recommendations, immunizations in patients with high-risk chronic conditions, and strategies for increasing vaccination rates.
https://immattersacp.org/weekly/archives/2021/07/20/2.htm
20 Jul 2021
Treatment for high-risk COVID-19 patients, vaccine news, research on health messaging
An industry-funded study found benefit with bamlanivimab plus etesevimab for high-risk ambulatory COVID-19 patients, the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine, and two studies looked at COVID-19 messaging for minority populations.
https://immattersacp.org/weekly/archives/2021/07/20/1.htm
20 Jul 2021
Nitrile gloves available at discounted prices from Project N95
ACP's personal protective equipment partner, Project N95, has an overstock of blue nitrile powder-free patient examination gloves available for immediate fulfillment.
https://immattersacp.org/weekly/archives/2021/07/13/2.htm
13 Jul 2021
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
Residents reimagine antiracism curriculum
Residents interested in diversity, equity, and inclusion are taking matters into their own hands, creating new training initiatives about the subject as a formal part of their medical school curriculum.
https://immattersacp.org/archives/2021/07/residents-reimagine-antiracism-curriculum.htm
1 Jul 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021